This complex modulates the m6A modification at the 5' end of c-MYC mRNA and the coding DNA sequence region (near the 5'UTR), thus regulating c-MYC expression and advancing the progression of pancreatic cancer [82]. This evidence concerns the gene MYC and familial pancreatic carcinoma.